176 related articles for article (PubMed ID: 31422224)
1. Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors.
Moi D; Foster PA; Rimmer LG; Jaffri A; Deplano A; Balboni G; Onnis V; Potter BVL
Eur J Med Chem; 2019 Nov; 182():111614. PubMed ID: 31422224
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.
El-Gamal MI; Semreen MH; Foster PA; Potter BV
Bioorg Med Chem; 2016 Jun; 24(12):2762-7. PubMed ID: 27143133
[TBL] [Abstract][Full Text] [Related]
3. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Lehr P; Billich A
J Med Chem; 2002 Sep; 45(19):4310-20. PubMed ID: 12213072
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
Ciobanu LC; Poirier D
J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.
Hng Y; Lin MH; Lin TS; Liu IC; Lin IC; Lu YL; Chang CN; Chiu PF; Tsai KC; Chen MJ; Liang PH
Bioorg Chem; 2020 Mar; 96():103618. PubMed ID: 32059152
[TBL] [Abstract][Full Text] [Related]
6. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
Lawrence Woo LW; Leblond B; Purohit A; Potter BV
Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of N-acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors.
Daśko M; Rachon J; Masłyk M; Kubiński K; Demkowicz S
Chem Biol Drug Des; 2017 Jul; 90(1):156-161. PubMed ID: 28032462
[TBL] [Abstract][Full Text] [Related]
9. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
10. A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.
El-Gamal MI; Zaraei SO; Foster PA; Anbar HS; El-Gamal R; El-Awady R; Potter BVL
Bioorg Med Chem; 2020 Apr; 28(8):115406. PubMed ID: 32173116
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Evaluation of Fluorinated 3-Phenylcoumarin-7-O-Sulfamate Derivatives as Steroid Sulfatase Inhibitors.
Demkowicz S; Daśko M; Kozak W; Krawczyk K; Witt D; Masłyk M; Kubiński K; Rachon J
Chem Biol Drug Des; 2016 Feb; 87(2):233-8. PubMed ID: 26280898
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495).
Woo LW; Ganeshapillai D; Thomas MP; Sutcliffe OB; Malini B; Mahon MF; Purohit A; Potter BV
ChemMedChem; 2011 Nov; 6(11):2019-34. PubMed ID: 21990014
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2003 May; 46(11):2197-204. PubMed ID: 12747791
[TBL] [Abstract][Full Text] [Related]
14. New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1
Ciupak O; Daśko M; Biernacki K; Rachon J; Masłyk M; Kubiński K; Martyna A; Demkowicz S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):238-247. PubMed ID: 33322953
[TBL] [Abstract][Full Text] [Related]
15. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
16. The Design, Structure-Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhibitors.
Chang CN; Lin IC; Lin TS; Chiu PF; Lu YL; Narwane M; Liu IC; Hng Y; Tsai KC; Lin MH; S Y Hsieh Y; Chen MJ; Liang PH
Bioorg Chem; 2022 Dec; 129():106148. PubMed ID: 36244324
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties.
Congiu C; Onnis V; Deplano A; Balboni G; Ceruso M; Supuran CT
Bioorg Med Chem; 2015 Sep; 23(17):5619-25. PubMed ID: 26233796
[TBL] [Abstract][Full Text] [Related]
18. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
19. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
Fischer DS; Woo LW; Mahon MF; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2003 Apr; 11(8):1685-700. PubMed ID: 12659755
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Winiski AP; Billich A
J Med Chem; 2003 Nov; 46(23):5091-4. PubMed ID: 14584960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
